Showing 1351-1360 of 5603 results for "".
Beyond Fulvestrant: Oral SERDs Redefining ER Targeting
https://reachmd.com/programs/cme/beyond-fulvestrant-oral-serds-redefining-er-targeting/39800/Examine evolving global strategies for treating patients with HR+/HER2- mBC, integrating biomarker-driven therapy, clinical evidence, and toxicity management.Not Just a Headache: Migraine Across Women’s Lifespan
https://reachmd.com/programs/cme/not-just-a-headache-migraine-across-womens-lifespan/36591/Review hormonal, diagnostic, and treatment considerations for migraine across women's life stages, including menstrual and menopausal transitions.Optimizing Outcomes: Evidence-Based Strategies for Treating Patients With Heart Failure With Mildly Reduced or Preserved Left Ventricular Ejection Fraction
https://reachmd.com/programs/cme/optimizing-outcomes-evidence-based-strategies-for-treating-patients-with-heart-failure-with-mildly-reduced-or-preserved-left-ventricular-ejection-fraction/29905/Optimizing Outcomes: Evidence-Based Strategies for Treating Patients With Heart Failure With Mildly Reduced or Preserved Left Ventricular Ejection FractionBreaking the Line: Moving Bispecific Antibodies Upstream in Treating Multiple Myeloma
https://reachmd.com/programs/cme/breaking-the-line-moving-bispecific-antibodies-upstream-in-treating-multiple-myeloma/49265/Learn how early-line bispecific antibodies are reshaping multiple myeloma treatment, supported by emerging efficacy and safety data from key clinical trials.Frontline Insights: Emerging Therapeutic Strategies in HNSCC
https://reachmd.com/programs/cme/Frontline-Insights-Emerging-Therapeutic-Strategies-in-HNSCC/49223/Review emerging therapeutic strategies in HNSCC across disease states and learn to compare safety profile to improve AE recognition, prevention, and management.FSGS 360°: From Patient Experience to Precision Medicine
https://reachmd.com/programs/cme/fsgs-360-from-patient-experience-to-precision-medicine/35905/FSGS 360°: From Patient Experience to Precision MedicineRemission: Can You Prove It?
https://reachmd.com/programs/cme/remission-can-you-prove-it/51486/Explore IBD from diagnosis to remission with practical cases, treatment strategies, and a treat-to-target approach for optimal patient outcomes.A Clear Horizon in Plaque Psoriasis: An Update on Investigational Oral Therapies
https://reachmd.com/programs/cme/a-clear-horizon-in-plaque-psoriasis-an-update-on-investigational-oral-therapies/37867/Join Drs. Armstrong and Stein Gold as they evaluate the clinical evidence and potential role of emerging oral systemic therapies in moderate to severe psoriasis.The Future of HNSCC: Aligning Teams, Transforming Care
https://reachmd.com/programs/cme/The-Future-of-HNSCC-Aligning-Teams-Transforming-Care/54394/Practice-changing data in resectable HNSCC? Experts unpack KEYNOTE-689, NIVOPOSTOP, and how to implement perioperative immunotherapy.Living With Systemic Mastocytosis: Bridging Clinical Decisions and Patient Realities
https://reachmd.com/programs/cme/living-with-systemic-mastocytosis-bridging-clinical-decisions-and-patient-realities/54389/Join us to explore the disease burden of systemic mastocytosis, evidence-based personalized care, and using multidisciplinary strategies to improve outcomes.